Skip to content

The Use of Stromal Vascular Fraction for Knee Arthrosis

Gebruik Van Stromale Vasculaire Fractie Uit Vetweefsel Na Invriezing Voor Knie Arthrose

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06171204
Enrollment
10
Registered
2023-12-14
Start date
2022-09-19
Completion date
2026-12-31
Last updated
2024-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Arthrosis

Brief summary

A trial to investigate the safety and efficacy of SVF for the treatment of knee arthrosis. Patients will undergo a single liposuction to obtain the SVF. The SVF will then be isolated and frozen in our laboratory. The SVF will then be injected up to 2 times into the fat pad of the patient's knee.

Detailed description

Stromal Vascular Fraction (SVF) from adipose tissue is increasingly being used in the clinic for a variety of conditions (skin disorders, joint pain, etc.). SVF is a collective term for cells that can be obtained from liposuction fat. These cells can be separated from the fat by mechanical processing of the liposuction fat combined with an additional centrifugation. Despite the fact that enough SVF can be isolated after such a liposuction for multiple treatments (\>3), our research group has found a way to safely freeze SVF without significant loss of SVF cells. In this way, a patient would only have to undergo one liposuction and associated anesthesia to be able to obtain multiple SVF treatments.

Interventions

PROCEDUREInjection of SVF in fat pad of the knee

Knee fat pad injection with SVF at orthopaedics/physical medicine outpatient clinic

Sponsors

University Hospital, Ghent
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Legal capacity * Osteochondral lesions * Inflammatory complaints * (Peri)tendinitis or tendinopathies and ligamentous injuries * Impingement complaints * Arthrofibrosis * Anterior knee pain

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of the safety of SVF injections after cryo preservation1 yearThe patient will complete the KOOS questionnaire (Knee Injury and Osteoarthritis Outcome Score) on several timepoints.

Countries

Belgium

Contacts

Primary ContactBernard Depypere, MD
bernard.depypere@ugent.be093325730
Backup ContactJessie De Kinder
jessie.dekinder@uzgent.be093321373

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026